Overview

Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Status:
Recruiting
Trial end date:
2023-08-15
Target enrollment:
Participant gender:
Summary
The primary efficacy endpoint for this study is the proportion of subjects with complete closure of Target Ulcer during the 20-week Treatment Phase, which is assessed by the blinded independent evaluator.
Phase:
Phase 3
Details
Lead Sponsor:
Oneness Biotech Co., Ltd.